Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
2017 · The Lancet Neurology · 900 citations
https://doi.org/10.1016/s1474-4422(17)30115-1
C
Chikuma Hamada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
198
Papers
6.6K
Citations
32
h-index
82
i10-index
Chikuma Hamada is an academic researcher from Tokyo University of Science. The author has contributed to research in topics: Statistical Methods in Clinical Trials & Colorectal Cancer Treatments and Studies & Optimal Experimental Design Methods. The author has an h-index of 32, co-authored 169 publications.
Papers by this author
worksSafety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
2017 · The Lancet Neurology · 900 citations
https://doi.org/10.1016/s1474-4422(17)30115-1
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study
2019 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/s41416-019-0410-0
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials
2017 · Contemporary Clinical Trials Communications · 1 citations
https://doi.org/10.1016/j.conctc.2017.05.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat